副研究员，硕士生导师，医学博士。现任中山大学附属第六医院科技处临床研究中心主任。 2007年自武汉大学医学院病原生物专业、病毒学国家重点实验室毕业。2013-2014美国Johns Hopkins大学医学院访问学者。主要研究方向为消化系统疾病与肠道微生态。作为项目负责人承担国自然项目、教育部项目2项，作为项目骨干参与二十余项；获授权实用新型专利2项。学术任职：省医学会医学科研实验室建设与管理分会委员会常委委员；广东省精准医学应用学会医学大数据与人工智能分会常务委员；广东省干（体）细胞临床研究质量控制中心专家组成员。
联系邮箱：hujun33@mail.sysu.edu.cn

近五年代表性论文：
1.Hu J, Chen W#, Zhu R, Yang F, Xu J, Xiang B, Li Y, Wang W, Zhu L, Chen G, Zhi M. Correction: Dietary risk factors in Crohn's disease and ulcerative colitis: a cohort study with paired healthy relatives as controls. Eur J Nutr. 2025 Apr 21;64(4):161. doi: 10.1007/s00394-025-03669-y. Erratum for: Eur J Nutr. 2025 Mar 12;64(3):123. doi: 10.1007/s00394-025-03598-w. PMID: 40257583.

2.Xiang B, Zhang Q, Wu H, Lin J, Xu Z, Zhang M, Zhu L, Hu J*, Zhi M*. Impact of Mild COVID-19 History on Oral-Gut Microbiota and Serum Metabolomics in Adult Patients with Crohn's Disease: Potential Beneficial Effects. Biomedicines. 2024 Sep 14;12(9):2103. doi: 10.3390/biomedicines12092103. PMID: 39335616; PMCID: PMC11429124.

3.Chen W, Li Y, Wang W, Gao S, Hu J, Xiang B, Wu D, Jiao N, Xu T, Zhi M, Zhu L, Zhu R. Enhanced microbiota profiling in patients with quiescent Crohn's disease through comparison with paired healthy first-degree relatives. Cell Rep Med. 2024 Jul 16;5(7):101624. doi: 10.1016/j.xcrm.2024.101624. Epub 2024 Jun 27. PMID: 38942021; PMCID: PMC11293350.

4.Hu J, Cheng S, Yao J, Lin X, Li Y, Wang W, Weng J, Zou Y, Zhu L, Zhi M. Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn's disease. Front Immunol. 2022 Aug 15;13:947313. doi: 10.3389/fimmu.2022.947313. PMID: 36045690; PMCID: PMC9420857.

5.Cheng S, Hu J#, Wu X, Pan JA, Jiao N, Li Y, Huang Y, Lin X, Zou Y, Chen Y, Zhu L, Zhi M, Lan P. Altered gut microbiome in FUT2 loss-of-function mutants in support of personalized medicine for inflammatory bowel diseases. J Genet Genomics. 2021 Sep 20;48(9):771-780. doi: 10.1016/j.jgg.2021.08.003. Epub 2021 Aug 20. PMID: 34419617.